These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21253743)

  • 1. [Monitoring treatment with biologics in non-infectious uveitis].
    Barisani-Asenbauer T
    Ophthalmologe; 2011 Jan; 108(1):21-4. PubMed ID: 21253743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review.
    Rosenbaum JT; Bodaghi B; Couto C; Zierhut M; Acharya N; Pavesio C; Tay-Kearney ML; Neri P; Douglas K; Pathai S; Song AP; Kron M; Foster CS
    Semin Arthritis Rheum; 2019 Dec; 49(3):438-445. PubMed ID: 31301816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopharmacotherapy of non-infectious uveitis: where do we stand?
    Agrawal R; Lee C; Phatak S; Pavesio C
    Expert Opin Biol Ther; 2014 Dec; 14(12):1719-22. PubMed ID: 25244075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
    Angeles-Han ST; Ringold S; Beukelman T; Lovell D; Cuello CA; Becker ML; Colbert RA; Feldman BM; Holland GN; Ferguson PJ; Gewanter H; Guzman J; Horonjeff J; Nigrovic PA; Ombrello MJ; Passo MH; Stoll ML; Rabinovich CE; Sen HN; Schneider R; Halyabar O; Hays K; Shah AA; Sullivan N; Szymanski AM; Turgunbaev M; Turner A; Reston J
    Arthritis Care Res (Hoboken); 2019 Jun; 71(6):703-716. PubMed ID: 31021540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of biologics for uveitis associated with spondyloarthritis.
    Arepalli S; Rosenbaum JT
    Curr Opin Rheumatol; 2019 Jul; 31(4):349-354. PubMed ID: 31107288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimising drug therapy for non-infectious uveitis.
    Shahab MA; Mir TA; Zafar S
    Int Ophthalmol; 2019 Jul; 39(7):1633-1650. PubMed ID: 29961190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of biologics for the treatment of noninfectious uveitis.
    Takeuchi M
    Immunotherapy; 2013 Jan; 5(1):91-102. PubMed ID: 23256801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and Biologics in non-infectious autoimmune uveitis: bench to bedside.
    Agrawal R; Iyer J; Connolly J; Iwata D; Teoh S
    Indian J Ophthalmol; 2014 Jan; 62(1):74-81. PubMed ID: 24492505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-TNF-α treatment for uveitis. Analysis of the current situation].
    Pleyer U; Mackensen F; Winterhalter S; Stübiger N
    Ophthalmologe; 2011 Jan; 108(1):13-20. PubMed ID: 21181169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety of biologics in dermatology.
    Lima XT; Seidler EM; Lima HC; Kimball AB
    Dermatol Ther; 2009; 22(1):2-21. PubMed ID: 19222513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uveitic macular edema].
    Fardeau C; Champion E; Massamba N; LeHoang P
    J Fr Ophtalmol; 2015 Jan; 38(1):74-81. PubMed ID: 25547721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of sight-threatening uveitis: new therapeutic options.
    Becker MD; Smith JR; Max R; Fiehn C
    Drugs; 2005; 65(4):497-519. PubMed ID: 15733012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prospects of the biotherapy for refractory uveitis].
    Zheng YZ
    Zhonghua Yan Ke Za Zhi; 2016 Jul; 52(7):551-6. PubMed ID: 27531117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on noninfectious uveitis in children and its treatment.
    Maccora I; Sen ES; Ramanan AV
    Curr Opin Rheumatol; 2020 Sep; 32(5):395-402. PubMed ID: 32675714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.
    Lerman MA; Rabinovich CE
    Paediatr Drugs; 2015 Aug; 17(4):283-301. PubMed ID: 25893479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uveitis for the non-ophthalmologist.
    Burkholder BM; Jabs DA
    BMJ; 2021 Feb; 372():m4979. PubMed ID: 33536186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile.
    Neri P; Arapi I; Nicolai M; Pirani V; Saitta A; Luchetti MM; Giovannini A; Mariotti C
    Curr Drug Saf; 2016; 11(1):47-54. PubMed ID: 26463249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 blockade in the management of non-infectious uveitis.
    Lopalco G; Fabiani C; Sota J; Lucherini OM; Tosi GM; Frediani B; Iannone F; Galeazzi M; Franceschini R; Rigante D; Cantarini L
    Clin Rheumatol; 2017 Jul; 36(7):1459-1469. PubMed ID: 28528519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.
    Sota J; Rigante D; Lopalco G; Frediani B; Franceschini R; Galeazzi M; Iannone F; Tosi GM; Fabiani C; Cantarini L
    Rheumatol Int; 2018 Jan; 38(1):25-35. PubMed ID: 28752230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study.
    Santos-Gómez M; Calvo-Río V; Blanco R; Beltrán E; Mesquida M; Adán A; Cordero-Coma M; García-Aparicio ÁM; Valls Pascual E; Martínez-Costa L; Hernández MV; Hernandez Garfella M; González-Vela MC; Pina T; Palmou-Fontana N; Loricera J; Hernández JL; González-Gay MA
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S34-S40. PubMed ID: 27054359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.